[The AGAT-R2, a gamma therapeutic apparatus with programmed control].
The paper is concerned with analysis of a new programmed-control gamma-therapeutic apparatus AGAT-P2 for gamma-beam therapy of cancer patients.
Biomedical subjects
Publications and source records attributed to V I Ermakov.
The paper is concerned with analysis of a new programmed-control gamma-therapeutic apparatus AGAT-P2 for gamma-beam therapy of cancer patients.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Clonogenic cells forming colonies in agar cultures in diffusion chambers and those isolated from subcutaneously transplanted Lewis lung carcinoma do not differ in their sensitivity to 60Co gamma-rays with respect to tumor growth stages. The dose-survival curves for all studied cells are S-shaped with a small shoulder. A cumulative dose-survival curve for malignant clonogenic cells is characterized by the average value of mean lethal dose D0 = 2.24 Gy and extrapolation number n = 2.0. When exposed to gamma-neutron-radiation (252Cf) malignant clonogenic cells exhibit a nearly exponential dose-survival curve with D0 = 0.56 Gy (with respect to a neutron component). The RBE of gamma-neutron radiation (252Cf) is 2.5.
Explore the source record for details and available documents.
Explore the source record for details and available documents.